Gene · 4837
Papers1,489
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,489
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Preliminary investigation of nicotinamide N-methyltransferase as an HBV-specific biomarker for hepatocellular carcinoma diagnosis. | Int J Biol Markers | 2025 | 40329575 | PubTator, text mining | PubMed |
| Nicotinamide N-Methyltransferase in the Inflammatory Pathogenesis of Graves' Orbitopathy. | Invest Ophthalmol Vis Sci | 2025 | 40310625 | PubTator, text mining | PubMed |
| 1,4-Dioxane Induces Epithelial-Mesenchymal Transition and Carcinogenesis in an Nrf2-Dependent Manner. | J Extracell Vesicles | 2025 | 40304624 | PubTator, text mining | PubMed |
| Correction: TTPAL promotes gastric tumorigenesis by directly targeting NNMT to activate PI3K/AKT signaling. | Oncogene | 2025 | 40275094 | PubTator, text mining | PubMed |
| LLMs and AI Life Models for Traditional Chinese Medicine-derived Geroprotector Formulation. | Aging Dis | 2025 | 40249926 | PubTator, text mining | PubMed |
| Nicotinamide N-methyltransferase as a potential therapeutic target for neurodegenerative disorders: Mechanisms, challenges, and future directions. | Exp Neurol | 2025 | 40221009 | PubTator, text mining | PubMed |
| Mechanism and kinetics of turnover inhibitors of nicotinamide N-methyl transferase in vitro and in vivo. | J Biol Chem | 2025 | 40209950 | PubTator, text mining | PubMed |
| The Missing Enzymes: A Call to Update Pharmacological Profiling Practices for Better Drug Safety Assessment. | J Med Chem | 2025 | 40173276 | PubTator, text mining | PubMed |
| Increased Sirtuin 6 Activity in Tumor Cells Can Prompt CD4-Positive T-Cell Differentiation Into Regulatory T Cells and Impede Immune Surveillance in the Microenvironment. | World J Oncol | 2025 | 40162112 | PubTator, text mining | PubMed |
| Nicotinamide metabolism reprogramming drives reversible senescence of glioblastoma cells. | Cell Mol Life Sci | 2025 | 40116940 | PubTator, text mining | PubMed |
| Heterogeneous and novel transcript expression in single cells of patient-derived clear cell renal cell carcinoma organoids. | Genome Res | 2025 | 40107723 | PubTator, text mining | PubMed |
| NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer. | Mol Cancer | 2025 | 40089784 | PubTator, text mining | PubMed |
| Role of Gut Microbial Metabolites in Ischemic and Non-Ischemic Heart Failure. | Int J Mol Sci | 2025 | 40076864 | PubTator, text mining | PubMed |
| Machine learning analysis identified NNMT as a potential therapeutic target for hepatocellular carcinoma based on PCD-related genes. | Sci Rep | 2025 | 40032894 | PubTator, text mining | PubMed |
| The complex role of glycine N-methyltransferase in metabolism-a review. | Mol Biol Rep | 2025 | 40025311 | PubTator, text mining | PubMed |
| Is N1-Methylnicotinamide a Good Organic Cation Transporter 2 (OCT2) Biomarker? | Metabolites | 2025 | 39997705 | PubTator, text mining | PubMed |
| NNMT is involved in deoxynivalenol-induced hepatocyte toxicity via promoting ferroptosis. | Toxicology | 2025 | 39983889 | PubTator, text mining | PubMed |
| Interactions between NAD+ metabolism and immune cell infiltration in ulcerative colitis: subtype identification and development of novel diagnostic models. | Front Immunol | 2025 | 39975557 | PubTator, text mining | PubMed |
| Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer. | Int Rev Cell Mol Biol | 2025 | 39939075 | PubTator, text mining | PubMed |
| PRDX6 Prevents NNMT Ubiquitination and Degradation as a Nonenzymatic Mechanism to Promote Ovarian Cancer Progression. | Adv Sci (Weinh) | 2025 | 39887931 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4837/papers?page=6